Literature DB >> 24992949

Oral versus short-term intratympanic prednisolone therapy for idiopathic sudden hearing loss.

Roberto Filipo1, Giuseppe Attanasio, Francesca Y Russo, Giulia Cartocci, Angela Musacchio, Andrea De Carlo, Raymond Roukos, Elio De Seta, Giacinto Di Tillo, Marika Viccaro, Pasquale Sarnacchiaro, Edoardo Covelli.   

Abstract

OBJECTIVES: To assess the therapeutic effectiveness of an intratympanic (IT) steroid protocol compared to a systemic steroid protocol.
METHODS: A total of 265 consecutive patients presenting unilateral idiopathic sudden sensorineural hearing loss were divided into 2 groups. One group comprised 131 patients enrolled between May 2009 and May 2010, and the other consisted of 134 patients enrolled between June 2010 and June 2011; a total of 48 patients were excluded among the 2 groups. The first group received oral prednisone for 8 days in tapering doses; the second group had IT prednisolone at a dose of 62.5 mg/ml once a day for 3 consecutive days. Audiological examinations were performed at study entry and 30 days after the beginning of therapy. Mean pure tone audiometry (PTA) of both groups and hearing outcomes following the criteria of Furuhashi et al. [Clin Otolaryngol 2002;27:458-463] and Siegel [Otolaryngol Clin North Am 1975;8:467-473] were investigated.
RESULTS: The strong efficacy of steroid therapy was evident in both groups, observing both PTA and hearing threshold improvement. The evaluation of the hearing outcomes shows a significantly better result for the short-term IT protocol; this result is ascribable to two types of audiometric curves: down- and up-sloping.
CONCLUSION: The results show a significant efficacy of both steroid therapeutic approaches. There was no significant difference in PTA improvement between the 2 study groups; the short-term IT protocol led to better results in the evaluation of the hearing outcomes (following the criteria of Siegel and Furuhashi et al.) for up- and down-sloping audiometric curves.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992949     DOI: 10.1159/000360069

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  8 in total

1.  Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

Authors:  Christian Mirian; Therese Ovesen
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

Review 2.  Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.

Authors:  Lilun Li; Tiffany Chao; Jason Brant; Bert O'Malley; Andrew Tsourkas; Daqing Li
Journal:  Adv Drug Deliv Rev       Date:  2016-01-12       Impact factor: 15.470

Review 3.  Early investigational drugs for hearing loss.

Authors:  Debashree Mukherjea; Sumana Ghosh; Puspanjali Bhatta; Sandeep Sheth; Srinivasan Tupal; Vikrant Borse; Thomas Brozoski; Kelly E Sheehan; Leonard P Rybak; Vickram Ramkumar
Journal:  Expert Opin Investig Drugs       Date:  2014-09-22       Impact factor: 6.206

4.  Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis.

Authors:  Yang Gao; Dong Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-12       Impact factor: 2.503

5.  Intraoperative Monitoring of the Cochlear Nerve during Neurofibromatosis Type-2 Vestibular Schwannoma Surgery and Description of a "Test Intracochlear Electrode".

Authors:  Anand V Kasbekar; Yu Chuen Tam; Robert P Carlyon; John M Deeks; Neil Donnelly; James Tysome; Richard Mannion; Patrick R Axon
Journal:  J Neurol Surg Rep       Date:  2019-02-04

Review 6.  Nanocarriers for Inner Ear Disease Therapy.

Authors:  Xiaoxiang Xu; Jianwei Zheng; Yanze He; Kun Lin; Shuang Li; Ya Zhang; Peng Song; Yuye Zhou; Xiong Chen
Journal:  Front Cell Neurosci       Date:  2021-12-03       Impact factor: 5.505

7.  Does the addition of a second daily session of hyperbaric oxygen therapy to intratympanic steroid influence the outcomes of sudden hearing loss?

Authors:  G Attanasio; E Covelli; L Cagnoni; E Masci; D Ferraro; P Mancini; E Alessandri; G Cartocci; R Filipo; M Rocco
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-10       Impact factor: 2.124

8.  Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss.

Authors:  Jared H Hara; Julia A Zhang; Krupa R Gandhi; Anna Flaherty; Wayne Barber; Marcia A Leung; Lawrence P Burgess
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.